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Background: Arsenic induced cell transformation and carcinogenesis.
Results: Arsenic-transformed cells have the property of apoptosis/autophagy resistance.
Conclusion: The constitutive activation of Nrf2 in arsenic-transformed cells up-regulates antioxidants, decreases ROS gener-
ation, and causes apoptosis resistance and tumorigenesis.
Significance: Antioncogenic role of inducible Nrf2 in normal cells and oncogenic role of constitutive activation of Nfr2 in
cancer cells may increase our understanding of the mechanism of arsenic carcinogenesis and its prevention.
Arsenic (As3) is a carcinogenwith considerable environmental
and occupational relevancy. The present study shows that As3-
transformed human lung bronchial epithelial BEAS-2B cells (AsT
cells) exhibit thepropertyof apoptosis resistance.The levelofbasal
reactiveoxygenspecies (ROS) is very low inAsTcells in correlation
with elevated expressions of both antioxidant enzymes and
antiapoptotic proteins. Nuclear factor erythroid 2-related factor
(Nrf2) and p62 are constitutively expressed. These two proteins
up-regulate antioxidant enzymes and antiapoptotic proteins. The
knockdown of Nrf2 or p62 by small interfering RNA (siRNA)
enhanced both ROS levels and As3-induced apoptosis in trans-
formed cells. AsT cells have autophagy deficiency as evidenced by
reduced formation ofmicrotubule-associated protein 1 light chain
3 (LC3)-II, GFP-LC3 puncta, and autophagy flux. Results obtained
using a soft agar assay and shRNANrf2-transfected cells show that
Nrf2 plays an antioncogenic role before transformation, whereas
this transcription factor plays an oncogenic role after transforma-
tion. In addition, depletion of Nrf2 by shRNA dramatically inhib-
ited growth and proliferation of transformed cells. Furthermore,
the Nrf2 protein levels and antiapoptotic and antioxidant enzyme
levels are higher in lung adenocarcinoma than in normal tissues.
Collectively, this studydemonstrates thataconstitutivelyhigh level
of Nrf2 in AsT cells up-regulates the antioxidant proteins catalase
and superoxide dismutase as well as the antiapoptotic proteins
Bcl-2 and Bcl-xL. The final consequences are decreased ROS gen-
eration and increased apoptotic resistance, cell survival and prolif-
eration, and tumorigenesis.
The nuclear factor erythroid 2-related factor (Nrf2)4 is a
master regulator of cellular antioxidant responses. Under
unstressed conditions, Nrf2 is degraded by proteasomal
machinery. However, under oxidative stress condition, Nrf2
translocates to the nucleus and activates antioxidant proteins
and detoxification enzymes (1). The p62/sequestosome 1 pro-
tein is a multifunction, ubiquitin-binding adapter protein that
serves multiple cellular functions for autophagy, apoptosis,
reactive oxygen species (ROS) signaling, and cancer develop-
ment (2, 3). The accumulated p62 competitively binds to the
Nrf2-binding site of Keap1 and promotes the constitutive acti-
vation ofNrf2 transcriptional programs (4). Thus, p62 accumu-
lation activates Nrf2 and Nrf2 target gene expression (5, 6).
In general, apoptosis serves as a natural barrier to tumor
development (7). The apoptoticmachinery is controlled by pro-
and antiapoptotic members of the Bcl-2 family (7). Cancer cells
have a variety of strategies to escape apoptosis such as the loss
of the p53 tumor suppressor and an increase in expression of
antiapoptotic proteins such as Bcl-2 and Bcl-xL (8, 9).
Autophagy is thought to play a dual role in carcinogenesis.
For example, autophagy helps tumor growth, metabolism, and
survival via nutrient recycling (10). However, autophagy can
prevent tumor initiation by suppressing inflammation, tissue
damage, and genomic instability through its quality control
function (11).
It has been reported that inducible Nrf2 activation reduces
carcinogenesis, especially in its early stages (12–14). It has been
shown that inducible Nrf2 activation is important in the anti-
cancer effects of many natural compounds, including phen-
ethyl isothiocyanate, curcumin, and resveratrol (12). However,
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a constitutively high level of Nrf2 protects cancer cells against
oxidative stress and chemotherapeutic agents (15). The antion-
cogenic or oncogenic role of Nrf2 may depend on the stage of
carcinogenesis. Nrf2 activity may be desirable in early stages of
carcinogenesis when the host is seeking to control premalig-
nant carcinogenesis, but constitutive Nrf2 activation may be
undesirable in later stages when it may induce resistance to
apoptosis in malignant cancer cells. Despite recent advances in
understanding the mechanism of As3-induced Nrf2 activa-
tion, the role of Nrf2 in As3-induced carcinogenesis (protec-
tion against or promotion of carcinogenesis) remains unex-
plored. The central hypothesis is that Nrf2 is antioncogenic in
early stages of As3-induced carcinogenesis (cell transforma-
tion) by an up-regulation of antioxidants to reduce As3-in-
duced ROS; however, once a cell is transformed, Nrf2 is onco-
genic by inducing apoptosis resistance. This study also will
examine howconstitutive activation ofNrf2 contributes to apo-
ptosis resistance as well as a decrease in ROS generation and
tumorigenesis in transformed cells.
Materials andMethods
Cell Culture andTreatment—Thehuman lung bronchial epi-
thelial cell line BEAS-2Bwas obtained from theAmerican Type
Culture Collection (Manassas, VA). As3-transformed cells
were generated as described previously (16). The transforma-
tion ability and tumorigenicity of the transformed cells were
confirmed by soft agar assay and xenograft assay, respectively.
Plasmids and Transfection—The overexpression of catalase,
SOD1, and SOD2 in BEAS-2B cells has been described previ-
ously (17). The mCherry-EGFP-LC3B plasmid was purchased
from Addgene (Cambridge, MA), and GFP-LC3 plasmid has
been described previously (18). shRNAs for knockdown of cat-
alase and SOD2 were obtained from (OriGene Technologies,
Inc., Rockville, MD). Transfections were performed using
LipofectamineTM 2000 (Invitrogen) according to the manufac-
turer’s protocol.
Nrf2 and p62 Knockdown—Silencer predesigned siRNAs for
human p62 (siRNA ID s16960) and Nrf2 (siRNA ID s9491) and
control siRNA (AM4611) were obtained fromAmbion (Austin,
TX). Four unique human 29-mer shRNA constructs in retrovi-
ral GFP vector for Nrf2 (TG311194) and p62 (TG309121) were
purchased from OriGene Technologies, Inc.
Chromatin Immunoprecipitation (ChIP) Assay—A ChIP
assay was performed using a PierceTM Agarose ChIP kit
(Thermo Scientific, Rockford, IL). Sheared chromatin was
diluted and immunoprecipitated with 2g of anti-Nrf2 or con-
trol IgG antibody. DNA-protein complexes were eluted from
the protein A/G-agarose beads using a spin column and reverse
cross-linked by incubatingwithNaCl at 65 °C.The relativeNrf2
binding to the ARE regions of p62, Bcl-2, and Bcl-xL was ana-
lyzed by the MyiQTM Single-Color Real-Time PCR Detection
System (Bio-Rad) with SYBR Green PCR Master Mix. General
PCR amplification was also performed using Mastercycler
thermal cyclers (Eppendorf, Foster City, CA).
Human Tissue Samples—Human lung adenocarcinoma tis-
sue (stage IA or IIA) was provided from the Biospecimen and
Tissue Procurement Shared Resource Facility of the University
of KentuckyMarkey Cancer Center. Frozen lung cancer tissues
were homogenized with MagNA Lyser Green Beads using a
MagNA Lyser instrument (Roche Applied Science), andWest-
ern blotting analysis was performed.
Immunohistochemical Staining—Tumor tissues were fixed
with 4% paraformaldehyde at room temperature for 24 h,
embedded in paraffin, and sectioned (3–4-m thickness). The
slides were deparaffinized, rehydrated, and processed for
immunohistochemical staining according to the VEC-
TASTAINABC kit protocol (Vector Laboratories, Burlingame,
CA).
Statistical Analysis—All the data are expressed as means 
S.E. One-way analysis of variance (ANOVA) using IBM SPSS
Statistics 21 was used for the multiple comparisons. A value of
p0.05 was considered statistically significant.
Results
As3-transformed BEAS-2B Cells Have the Property of Cell
Death Resistance—Arsenic-induced transformed BEAS-2B
cells (AsT cells) showed less cell death when these cells were
exposed to As3 compared with non-transformed cells (Fig. 1,
A–C). The AsT cells had a higher proliferative potential and
colony forming ability than the non-transformed BEAS-2B
cells (Fig. 1, D and E). Approximately 30% of cell populations
were apoptotic in the As3-exposed normal cells. However,
apoptosis occurred only in a few cell populations in AsT cells
(Fig. 1, F andG). The cleaved poly(ADP-ribose) polymerase and
caspase-3/7 expression was dose-dependent in the non-trans-
formed cells but not in AsT cells (Fig. 1H). Further study
revealed that As3-induced cell death occurredmainly through
caspase-dependent apoptosis (Fig. I).
A Low Level of ROS Is Caused by High Expressions of Antiox-
idant Enzymes, and High Expressions of Bcl-2 and Bcl-xL Are
Involved in Cell Death Resistance Mechanisms of AsT Cells—
Electron spin resonance (ESR) measurements show that the
normal BEAS-2B cells generated a high 1:2:2:1 quartet signal
indicative of ROS generation and that the signal was very low in
the AsT cells (Fig. 2A). Furthermore, we stained the cells with
5-(and-6)-chloromethyl-2,7-dichlorodihydrofluorescein
diacetate to measure intracellular ROS levels and analyzed
fluorescence intensity using flow cytometry (Fig. 2B), fluores-
cence microscopy (Fig. 2C), and a fluorescence microplate
reader (Fig. 2D). The expressions of catalase and superoxide
dismutase 2 were much higher in AsT cells than in non-trans-
formed parent cells (Fig. 2E). When the cells were exposed to
As3, the expressions of antioxidant enzymeswere reduced in a
dose-dependent manner in normal BEAS-2B cells, whereas the
levels of antioxidant enzymeswere only slightly decreased upon
exposure toAs3 at 20M in theAsT cells (Fig. 2F). The knock-
down of these antioxidant enzymes by shRNA transfection in
the AsT cells restored the levels of ROS (Fig. 2G). The basal
levels of Bcl-2 and Bcl-xL were higher in the AsT cells than in
the non-transformed cells (Fig. 2H). The decrease in the levels
of Bcl-2 and Bcl-xL by As3 was much lesser in AsT cells in a
dose- and time course-dependent manner (Fig. 2, I and J).
Depletions of Bcl-2 andBcl-xL expressions by addingABT-263,
a Bcl-2 family inhibitor, resulted in complete inhibition of Bcl-2
and Bcl-xL expressions (Fig. 2K). The viability of As3-exposed
Dual Role of Nrf2 in Arsenic Carcinogenesis
NOVEMBER 6, 2015•VOLUME 290•NUMBER 45 JOURNAL OF BIOLOGICAL CHEMISTRY 27091
 by guest on D
ecem
ber 1, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
transformed cells is similar to that of non-transformed cells
(Fig. 2L).
Nrf2 and p62 Play a Critical Role for Cell Survival and Apo-
ptosis Resistance of the AsT Cells—The basal levels of Nrf2 and
p62were higher inAsT cells than in non-transformed cells (Fig.
3, A and F). When normal cells were exposed to As3, the
expression levels of Nrf2 and p62 were slightly increased. In
AsT cells, the increased expression level was dramatic (Fig. 3,B,
C, G, and H). The Nrf2 downstream target proteins NAD(P)H
dehydrogenase, quinone 1 (NQO1) and HO-1 were elevated in
the AsT cells (Fig. 3C). The Nrf2 negative regulator Keap1 was
less expressed inAsT cells than in normal BEAS-2B cells (Fig. 3,
B and C). Moreover, the Keap1 expression level decreased by
As3 was restored after 12 h and started to increase in the
BEAS-2B cells but not in the AsT cells (Fig. 3C). To further
study the roles of Nrf2 and p62 in cell death resistance, we
inhibited Nrf2 and p62 expressions by siRNA transfection (Fig.
3, D and I). The As3-mediated apoptosis was greatly acceler-
ated by the blockage of Nrf2 or p62 expression in AsT cells (Fig.
3, E and J).
Nrf2 and p62 Cross-talk and As3 Increase the Binding of
Nrf2 to ARE Region of the p62/Bcl-2/Bcl-xL Promoter—After
Nrf2 was knocked down, the basal level and increased level
of Nrf2 by As3 were abolished along with the p62 level (Fig.
FIGURE 1. AsT cells have cell death resistance, high proliferation, and tumorigenic potential. AsT cells and their parent non-transformed BEAS-2B cells
were exposed to increasing concentrations (0–50M) of As3 for 24 h. The cell morphology was visualized bymicroscopy (A), and the 3-(4,5-dimethylthiazol-
2yl-)-2,5-diphenyltetrazolium bromide assay results are presented by either photograph (B) or graph (C). The AsT cells and non-transformed cells (0.2 106)
were seededon10-cmculture dishes for 7 days. The total cell numberwas counted eachday (D). AsT andnormal BEAS-2B cells (1 106)were seededon10-cm
culture dishes. During culture periods, colony formation was observed (E). Cells were exposed to As3 for 24 h, stained with annexin V and propidium iodide
(PI), and then analyzed by a flow cytometer (F and G). The levels of poly(ADP-ribose) polymerase (PARP) and cleaved (c) caspase-3/7 were determined by
Western blotting analysis (H). Cells were incubated with As3 (20 M) for 24 h in the presence and absence of the pancaspase inhibitor Z-VAD (20 M) and an
apoptosis assaywas performed (I).Cont, control. The results are shown as themean S.E. of triplicate or three independent experiments. ###, p 0.001 versus
the same concentration of arsenic-treated cells. *, p  0.05; **, p  0.01; and ***, p  0.001 represent the significant differences between the experiments
(ANOVA and Scheffé’s test). Error bars represent S.E. GAPDH was used as a loading control. Scale bars in A and E, 200 m.
Dual Role of Nrf2 in Arsenic Carcinogenesis
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4A). Furthermore, depletion of p62 reduced the basal level and
As3-exposed normal and AsT cell p62 and Nrf2 levels (Fig.
4A). These results reveal that Nrf2 and p62 cross-talk with each
other in the As3-exposed cells. The results of the ChIP assay
demonstrate that Nrf2 binding to the ARE F5 (493 to481)
in the p62 gene promoter was slightly increased in response to
As3 treatment in the normal BEAS-2B cells, whereas the bind-
ing was dramatically enhanced in AsT cells (Fig. 4, B and C).
The decreased levels of Bcl-2/Bcl-xL expressions by As3 and
basal levels of Bcl-2/Bcl-xL were further accelerated by siRNA
Nrf2 or p62 transfection in AsT cells (Fig. 4D, lower panel).
ChIP analysis revealed that Nrf2 binds to the ARE region of the
Bcl-2 promoter (F1, 2991 to 2980) and that binding to the
Bcl-xL promoter (F1, 2992 to 2984) increased in As3-ex-
posed transformed cells (Fig. 4, E and F).
As3-transformed BEAS-2B Cells Have the Property of
Autophagy Deficiency—When compared with normal cells, the
expression levels of autophagy-related proteins such as ATG3,
ATG5, and ATG7 were low in AsT cells without (Fig. 5A) and
with As3 treatment (Fig. 5B). As3 treatment dramatically
increased the LC3-II level in the normal cells, and LC3-II did
not accumulate significantly in the AsT cells (Fig. 5B). Fluores-
FIGURE 2.AsT cells have a low level of ROS andhighly express antioxidant enzymes andBcl-2/Bcl-xL proteins. The cell suspensionswere prepared from
AsT or normal cells, and then ESR spectra were recorded. The generation of a 1:2:2:1 quartet ESR signal is shown (A). ROS levels of the AsT cells and their parent
BEAS-2B cells also were measured using flow cytometry (B), fluorescence microscopy (C), and a fluorescence microplate reader (D) after staining with 5-(and-
6)-chloromethyl-2,7-dichlorodihydrofluorescein diacetate (DCF) (5 M) for 30 min. The basal cellular levels of catalase (CAT), SOD2, Bcl-2, and Bcl-xL were
measured (E andH). The ROS levelsweremeasured after knockdownof catalase or SODby shRNA transfection in theAsT cells (G). The effects of As3 (0–20M)
on the antioxidant enzymes and antiapoptotic proteins in the AsT cells or normal cells also were analyzed by Western blotting (F, I, and J). In addition, the
quantification of Bcl-2 levels is represented (J, lower panel). For the inhibition assay, cells were incubatedwith As3 (20M) for 24 h in the presence or absence
of ABT-263 (ABT; 10 M). Thereafter, the expression levels of Bcl-2 and Bcl-xL were detected (K), and cell viability was determined (L). The results are shown as
themean S.E. (error bars) of three separate experiments. *, p 0.05 and **, p 0.01 versus the normal BEAS-2B cells and ***, p 0.001 represent a significant
difference between the experiments (ANOVA and Scheffé’s test). ABT-263 is a Bcl-2 family inhibitor. Scale bars in C, 100 m. Cont, control.
Dual Role of Nrf2 in Arsenic Carcinogenesis
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cent puncta increased in both normal and transformed
BEAS-2B cells when treated with As3, but significantly fewer
puncta were observed in AsT cells (Fig. 5, C and D). Increased
LC3-II levels were observed with bafilomycin A1 (an inhibitor
of autophagosome and lysosome fusion) treatment in both
BEAS-2B cells and transformed cells. LC3-II levels were further
increased when treated with a combination of As3 and bafilo-
mycin A1, suggesting that As3 increased autophagy flux
rather than blocking the fusion of autophagosomes with lyso-
somes in BEAS-2B cells (Fig. 5, E and F). When the BEAS-2B
cells were treated with As3 in the presence of wortmannin, an
inhibitor of autophagosome initiation, the As3-induced up-
regulation of LC3-II was attenuated (Fig. 5, E, bottom, and F).
To further study autophagy flux in the normal or transformed
cells, we used tandem fluorescence-tagged LC3. When the
transfected cells were exposed to As3, both yellow
(mCherry/GFP) (autophagosome) and red (mCherry/
GFP) (autolysosome) puncta were increased in normal
BEAS-2B cells, whereas only yellow puncta with low intensity
were increased in AsT cells (Fig. 5, H and I). Each image of
FIGURE 3. Nrf2/p62 plays a critical role for cell survival and cell death resistance in the AsT cells. The basal expression levels of Nrf2 and p62 were
measured in theAsT cells and non-transformedBEAS-2B cells (A and F). The normal andAsT cells were exposed to various concentrations of As3 (0–20M) for
24 h (B andG) or various times (0–24 h)with 20MAs3 (C andH), and then the levels of Nrf2, Keap1, p62, hemeoxygenase-1 (HO-1), andNQO1were detected.
To diminish Nrf2 or p62 levels, cells were transfected with siRNA specific to Nrf2 or p62. After overnight transfection, cells were exposed to 20 M As3 for an
additional 24 h (D and I), and an apoptosis assaywas performed (E and J). The expression levels of Nrf2 or p62were quantified and are represented in the lower
panels. The results represent themean S.E. (error bars) of three independent experiments. *, p 0.05; **, p 0.01; and ***, p 0.001 represent a significant
difference between the experiments (ANOVA and Scheffé’s test). S, short exposure; L, long exposure; Cont, control.
Dual Role of Nrf2 in Arsenic Carcinogenesis
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GFP and mCherry is provided (Fig. 5H, top and middle).
These results together with those in Fig. 5, A–G, indicate that
autophagosomeswere fusedwith lysosomes to generate autoly-
sosomes in BEAS-2B cells but not in As3-transformed
BEAS-2B cells. The relatively strong autophagy flux was
induced by rapamycin alone, and As3 exhibited some inhibi-
tion as shown by decreased levels of autophagosomes and
autolysosomes (Fig. 5,H and I). These results show that As3 is
able to decrease the stress-activated autophagy flux in BEAS-2B
cells. In transformed BEAS-2B cells, rapamycin alone induced
autophagy flux at a lower level than that of normal BEAS-2B
cells, showing that the transformed BEAS-2B cells indeed have
some autophagy deficiency compared with their parent non-
transformed BEAS-2B cells (Fig. 5, H and I). Similar to the
results obtained using non-transformed cells, As3 was able to
decrease stress-induced autophagy flux in transformed
BEAS-2B cells. Taken together, the above autophagy flux
results indicate that the autophagy process was uncompleted in
the AsT cells. The expression levels of LC3-II in response to
rapamycin and starvation condition (Fig. 5G) and lower level of
ubiquitinated p62 (Fig. 5J) further confirmed autophagy defi-
ciency in the AsT cells compared with the normal BEAS-2B
cells. The results of the immunoprecipitation assay reveal that
the high expression of Bcl-2 in the AsT cells may alter Beclin1
activity even though the Beclin1 expression levels were not dif-
ferent between these two types of cells (Fig. 5K). The results of
the cell viability assay reveal that As3-induced autophagy was
involved in the cell death mechanism rather than the cell sur-
vival mechanism because the autophagy activator rapamycin
accelerated As3-induced cell death, whereas the autophagy
inhibitor wortmannin attenuated it (Fig. 5L). Moreover, As3-
induced apoptosis was significantly attenuated in autophagy-
FIGURE 4.Nrf2 and p62 have a positive feedback loop, and the binding activities of Nrf2 to the ARE regions of the p62, Bcl-2, and Bcl-xL promoters were
increasedinthearsenic-exposedAsTcells.CellsweretransfectedwithsiRNAspecific top62orNrf2.After12hof transfection, thecellsweretreatedwith20MAs3
for an additional 24 h. The expression levels of p62, Nrf2, heme oxygenase-1 (HO-1), and Bcl-2/Bcl-xLwere analyzed (A andD). The expression levels of Nrf2/p62 and
Bcl-2/Bcl-xLwerequantifiedandarerepresentedinA (lowerpanel)andD (lowerpanel), respectively.For theChIPassay,cellsweretreatedwithAs3 (20M) for6h, fixed
with formaldehyde, andcross-linked, and thenchromatinwas isolated. The chromatinwas immunoprecipitated (IP)with ananti-Nrf2 antibodyor controlmouse IgG.
TheNrf2 binding to the p62, Bcl-2, and Bcl-xL promoterswas analyzed by normal real time PCR (B and E) or quantitative real time PCR (C and F) with a primer specific
for theARE regionof thepromoter. Thedata represent thepercent input andare normalized to each control. The results are expressed as themean S.E. (error bars)
relative to the control of triplicate experiments. *, p 0.05 and ***, p 0.001 versus the untreated transformed control cells; ###, p 0.001 versus the As3-treated
transformed cells (ANOVA and Scheffé’s test). Actinwas used as a loading control. Cont, control.
Dual Role of Nrf2 in Arsenic Carcinogenesis
NOVEMBER 6, 2015•VOLUME 290•NUMBER 45 JOURNAL OF BIOLOGICAL CHEMISTRY 27095
 by guest on D
ecem
ber 1, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
defective Beclin1 knockdown cells when compared with the
vehicle control (Fig. 5M). This result corresponded to the GFP-
LC3 punctum-positive cell population (Fig. 5N).
Nrf2 and p62 Regulate Intracellular ROS Levels, and ROS Is a
Primary Initiator of Nrf2 and p62 Induction—The low basal
levels of ROS were up-regulated in the siRNA p62- or in the
FIGURE 5. AsT cells are characterized as having autophagy deficiency. The basal expression level of autophagy-related proteins (ATG3, ATG5, and ATG7)
weremeasured (A). Cells were exposed to various concentrations of As3 (0–20M) for 24 h, and then the levels of LC3, ATG3, ATG5, and ATG7were detected
(B). The cellswere transfectedwith theGFP-LC3plasmid, treatedwithAs3, and visualized (C), and thenumber of GFP-LC3punctum-positive cellswas counted
(D). To analyze autophagy flux, the cells were preincubated with bafilomycin A1 (Baf) (100 nM) or wortmannin (Wort) (100 nM) for 1 h before treatment with
As3. After 24-h incubation, the levels of LC3-I and LC3-II were detected (E). The expression level of LC3-II was quantified and is represented in F. The expression
levels of LC3-I and LC3-II were further analyzed after exposure to rapamycin (10 nM) or in starvation condition (G) for further confirmation of autophagy
deficiency of the AsT cells. The binding affinity of Bcl-2 with Beclin1 was analyzed by immunoprecipitation (K). The ubiquitination of p62 was further analyzed
using anti-ubiquitin after performing immunoprecipitation (IP) (J). In addition, the cellswere transfectedwith themCherry-EGFP-LC3plasmid and treatedwith
As3. The yellow puncta (mCherry/GFP) and red puncta (mCherry/GFP) were visualized using fluorescencemicroscopy (H), and quantification of puncta
is represented in I. For the inhibition assay, cells were incubated with As3 (20 M) for 24 h in the presence and absence of rapamycin (Rapa) (100 nM) or
wortmannin (100 nM). Thereafter, cell viability was determined (L). The shRNA Beclin1-transfected stable BEAS-2B cells were treated with As3 (0–20 M) for
24 h, and the apoptotic cells (M) and fluorescent punctum-positive cells (N) were determined. The results are shown as themean S.E. (error bars) in triplicate
or three independentexperiments. *,p0.05; **,p0.01; and***,p0.001 represent a significantdifferencebetween theexperiments (ANOVAandScheffé’s
test). Scale bars, 20 (C) and 50 m (H). Cont, control.
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siRNANrf2-transfected transformed cells as shown by fluores-
cence microscopy (Fig. 6A), fluorometric assay (Fig. 6B), and
ESR (Fig. 6, C and D). Furthermore, the expressions of antioxi-
dant enzymes were further reduced in As3-exposed Nrf2 or
p62 knockdown cells (Fig. 6E). The induction of Nrf2 or p62 by
As3 was attenuated with the endogenous overexpression of
catalase, SOD1, or SOD2 (Fig. 6F). Our data revealed that the
increased cleaved caspase-3 or LC3-II level was attenuated by
endogenous overexpressed antioxidant enzymes (Fig. 6F).
Moreover, As3-induced cell death was diminished by the
depletion of ROS using endogenous antioxidant enzymes (Fig.
6G).
Role of Nrf2 in As3-induced Malignant Cell Trans-
formation—Over the course of 6 months, BEAS-2B cells were
exposed to As3, and colony numbers gradually increased (Fig.
7A). During the period of 2–3 months of exposure, As3-ex-
posed shRNA Nrf2 or p62-transfected cells generated a higher
level of colony numbers than 2–3-monthAs3-exposed vehicle
control (Fig. 7A). However, at 4 months of As3 exposure, cells
with Nrf2 or p62 shRNA transfection exhibited less colony for-
mation when compared with As3-exposed vehicle control
during the same period (Fig. 7A). The inhibition effects on the
colony formation by knockdown of Nrf2 or p62 were further
enhanced at an exposure duration of 5 or 6 months (Fig. 7A).
The xenograft assay also demonstrated that the tumor growth
increased in the 2-month As3-exposed Nrf2 knockdown
BEAS-2B cells. The tumor growth was attenuated for 6-month
As3-exposed Nrf2 knockdown cells compared with As3-ex-
posed BEAS-2B cells used as a control (Fig. 7B). The growth of
transformed cells on agar was dramatically inhibited by either
Nrf2 shRNA or p62 shRNA transfection (Fig. 7E). The number
of colonies was also attenuated by shRNA Nrf2- or p62-trans-
fected AsT cells in the clonal assay (Fig. 7F).
The Expressions of Nrf2 and Its Related Proteins in Lung
Adenocarcinoma—The expression levels of Nrf2, its down-
stream target protein NQO1, and p62 were dramatically
increased in lung tumor tissues when compared with normal
tissues from the same patients (Fig. 7D). However, the Keap1
expression levels were lower in all lung tumor tissues than in
normal tissues (Fig. 7D). These results suggest that high expres-
sion of p62 along with down-regulation of Keap1 confers Nrf2
activation in lung adenocarcinoma. The antioxidant enzymes
(catalase and SOD2) and antiapoptotic proteins (Bcl-2 and Bcl-
xL) were highly expressed in lung tumor tissues (Fig. 7D). The
high levels of expressions of Nrf2 and p62 in patient samples
were further confirmed by immunohistochemistry (Fig. 7C).
The malignance of tumor tissue was confirmed by ki67 and
hematoxylin and eosin (H&E) staining (Fig. 7C).
Discussion
As3 is a group I human carcinogen and ranks first on the
Agency for Toxic Substance and Disease Registry 2013 Priority
FIGURE 6. Nrf2 and p62 regulate intracellular ROS levels. ROS are a primary regulator of Nrf2 and p62 expression and the main mediator of apoptotic and
autophagic cell death. AsT cells were transfectedwith siRNA specific toNrf2 or p62. After overnight transfection, ROS levelsweremeasured using fluorescence
microscopy (A), a fluorescencemicroplate reader (B), and ESR (C andD). Cells were transfectedwith siRNA specific to p62 or Nrf2. After 12 h of transfection, the
cells were exposed to 20 M As3 for an additional 24 h. The expression levels of catalase and SOD2 were measured (E). In addition, the catalase-, SOD1-, and
SOD2-overexpressing stable BEAS-2B cells were exposed to As3 (20M). The expression levels of p62, Nrf2, cleaved (c) caspase-3, and LC3 were analyzed (F),
and then cell viability was determined (G). The results are shown as themean S.E. (error bars) in triplicate experiments or three separate experiments. **, p
0.01and***,p0.001 versus theunexposedBEAS-2Bcells or thevehicle control (ANOVAandScheffé’s test). Scale bars inA, 100m.CAT, catalase;Cont, control;
DCF, 5-(and-6)-chloromethyl-2,7-dichlorodihydrofluorescein diacetate.
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List of Hazardous Substances (19). Occupational or environ-
mental exposure to As3 induces lung cancer (20). Occupa-
tional As3 exposure mainly occurs in mining, manufacturing,
wood preservation, and agriculture (21). Cigarette smoke,
As3-contaminated food, and As3-contaminated water are
non-occupational sources of human exposure to As3 (22).
Our previous study has shown that chronic exposure of human
bronchial epithelial cells to As3 generates ROS and that ROS
are responsible for As3-induced transformation of these cells
(16). In our present study, we have shown that As3-trans-
formed cells have a low level of ROS along with highly
expressed antiapoptotic proteins (Bcl-2 and Bcl-xL) and anti-
oxidant enzymes (catalase and SOD2) as well as Nrf2 and p62.
We have also shown that As3-transformed cells have the
properties of apoptosis resistance and autophagy dysfunction.
Most types of cancer cells show an apoptosis resistance and
have a high proliferative potential (23). Our present study
shows thatAsT cells exhibit apoptosis resistance. The cell death
resistance of AsT cells might be due to high expression of Bcl-2
and Bcl-xL based on the following results: 1) the basal levels of
Bcl-2 and Bcl-xL are higher in AsT cells and 2) AsT cells show
higher expression of Bcl-2/Bcl-xL than non-transformed cells
when exposed to As3 (Fig. 2,H–L). Another factor contribut-
ing to the apoptosis resistance is the low level of ROS in AsT
cells. These cells carry a low level of ROS, making the cells less
sensitive to As3 toxicity (Fig. 2, A–D). Furthermore, higher
expressions of antioxidant enzymes such as catalase and SOD2
help keep a low ROS concentration and contribute to cell death
resistance in the AsT cells (Fig. 2, E–G) because knockdown of
these antioxidant enzymes using shRNA in the AsT cells
restored the low levels of ROS in these cells to the normal range
(Fig. 2G). Nrf2 acts as a regulator of antioxidant and antiapo-
ptotic proteins in As3-exposed cells (Figs. 6, A–D, and 3E).
Nrf2 contributes to maintaining a low level of ROS due to up-
regulation of catalase and SOD2 in the AsT cells (Fig. 6E). Nrf2
also activates the antiapoptotic proteins Bcl-2 and Bcl-xL in
As3-exposed AsT cells (Fig. 4, D–F). The up-regulation of
antiapoptotic proteins by Nrf2 might play a major role in apo-
ptosis resistance in the As3-transformed cells.
Autophagy involves a cell death pathway, not a survival func-
tion, in our experimental setting because cell viability was
enhanced by the addition of pharmacological inhibitors or the
genetic depletion of autophagy in the As3-exposed normal
BEAS-2B cells (Fig. 5, L and M). Moreover, cell viability is
decreased by the addition of rapamycin, an autophagy activator
(Fig. 5L). These results suggest that defective autophagy in the
transformed cells has a beneficial effect for survival mecha-
nisms. It has been reported that dysfunction of autophagy or
defective autophagy causes up-regulation of p62 (24, 25). Our
data show that AsT cells are characterized by autophagy defi-
ciency (Fig. 5), whichmay result in the high expression of p62 in
transformed cells (Figs. 3F and 5). Notably, up-regulation of
Bcl-2/Bcl-xL may further contribute to dysregulation of
autophagy in the transformed cells as Bcl-2/Bcl-xL inhibits the
autophagy function through the binding of the BH-3 domain of
Beclin1, which is necessary for the induction of autophagy (26).
Our findings also demonstrate that the binding of Bcl-2 with
Beclin1was higher in theAsT cells than in the normal BEAS-2B
cells (Fig. 5K). Accumulation of p62 in transformed cells may
contribute to apoptosis resistance and tumorigenesis (Figs. 3,
F–J, and 7) through down-regulation of ROS generation (Fig. 6,
A–E). Depletion of p62 by siRNA transfection resulted in a
decrease of As3-induced Nrf2 expression in transformed cells
(Fig. 4A). Knockdown ofNrf2 by siRNA transfection also atten-
uated As3-induced p62 expression in the AsT cells (Fig. 4A).
These results indicate a possible positive feedback loop
between Nrf2 and p62 in the transformed cells. Furthermore,
Nrf2 binding activities on p62 promoter were dramatically
enhanced in the transformed cells upon exposure to As3 (Fig.
4, B and C). This might be the main reason for the increase of
p62 levels during As3 exposure periods in the cells (Fig. 3, G
andH). It is notable that the basal high level of p62 in the trans-
formed cells is not a direct cause of Nrf2 activation because
activation of Nrf2 binding to the ARE region of the p62 pro-
moter was not higher in the non-stimulated AsT cells than in
the normal cells (Fig. 4, B and C). Presumably, high expression
of p62 ismainly due to autophagy deficiency in the transformed
cells.
The expression of Nrf2 or p62 was markedly higher in the
lung adenocarcinoma tissues than in normal tissues from the
same patients (Fig. 7, C and D). Furthermore, other Nrf2 regu-
lator proteins such as antioxidant enzymes (catalase and SOD2)
and antiapoptotic proteins (Bcl-2 and Bcl-xL) along with Nrf2
downstream target protein NQO1 were highly expressed in
lung adenocarcinoma tissues (Fig. 7D). These results support
the pathological significance of Nrf2 and p62 signaling in
human lung cancer. However, Nrf2 has a protective role in cell
transformation during premalignant stages because As3-in-
duced cell transformationwas further enhanced by knockdown
of Nrf2 by shRNA transfection after 2 or 3 months of exposure
(Fig. 7,A and B). It is likely that inducible Nrf2 is antioncogenic
due to up-regulation of antioxidants to reduce the levels of
ROS, leading to decreased cell transformation. The protective
function of Nrf2 in the cells against cell transformation might
be lost when the cells are exposed to As3 continually. Further-
more, the protective role of Nrf2 in cell transformation is
reversed after 4 months of As3 exposure (Fig. 7, A and B). At
this stage, the constitutive activation of Nrf2 may promote cell
survival and increase cell proliferation by induction of apopto-
sis resistance of genetically damaged cells. These results suggest
that Nrf2 has an antioncogenic or oncogenic role depending on
the stage of cell transformation. Overall, this study demon-
FIGURE 7. Antioncogenic or oncogenic role of Nrf2 and its critical role in lung adenocarcinoma development. BEASE-2B cells in which Nrf2 or p62 was
knocked downwith shRNA transfection were exposed to 100 nM As3 for 6 months, and soft agar (A) and xenograft assays (B) were performed. AsT cells were
transfectedwith shRNA specific for either Nrf2 or p62, and then a soft agar assay (E) and clonal assay (F) were performed. Human lung adenocarcinoma tissues
(stage IA or IIA) were homogenized, and Western blotting analysis (D) or immunohistochemical staining (C) was performed. The results are shown as the
mean S.E. (error bars) in three independent experiments. *, p 0.05; **, p 0.01; ***, p 0.001 versus the As3-exposed vehicle control or the untreated
vehicle control cells (ANOVAandScheffé’s test). Actinwasusedas an internal control. 1550, stage IIA; 1294, stage IIA; 1048, stage IA.G, schemeshowing thedual
role of Nrf2 in As3-exposed human bronchial epithelial cells. Scale bars in C and E, 50 m. CAT, catalase; Cont, control; N, normal; T, tumor.
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strates the integration of Nrf2, p62, ROS, autophagy, apoptosis,
and cell survival in As3-induced carcinogenesis (Fig. 7G).
As3-induced ROS have been shown to have oncogenic prop-
erties in the premalignant stage; exposure of human lung bron-
chial epithelial cells to As3 generates ROS, which are respon-
sible for malignant transformation of these cells (16). In this
stage, the Nrf2 is inducible and is regulated by Keap1. By up-
regulating antioxidant enzymes to reduce ROS, this very well
regulated protein has an antioncogenic property. Notably, the
up-regulation of antiapoptotic proteins by Nrf2 is negligible in
the premalignant stage. After transformation (e.g. the postma-
lignant stage), ROS play an antioncogenic role. A low level of
ROS increases survival and proliferation of transformed cells
and tumorigenesis. In this stage, constitutive overexpression of
Nrf2 has an oncogenic property. This protein is mainly regu-
lated by p62 rather than Keap1. Its inducible property is lost.
The constitutive overexpression of Nrf2 further up-regulates
antioxidant enzymes and antiapoptotic proteins in the trans-
formed cells. These phenomenon cause low cellular ROS levels
and the acquisition of apoptosis resistance. Furthermore, high
expression of p62 due to defective autophagy leads to acceler-
ated Nrf2 activation. This process promotes cell survival, pro-
liferation, and carcinogenesis of transformed cells.Our findings
provide a potential chemoprevention and chemotherapy strat-
egy for metal-induced carcinogenesis through manipulation of
Nrf2 expression and activity.
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